OncoSec Medical Incorporated (ONCSQ)
OTCMKTS: ONCSQ · Delayed Price · USD
0.0003
0.00 (0.00%)
Apr 29, 2024, 1:02 PM EDT - Market open
OncoSec Medical Balance Sheet
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.3 | 45.95 | 20.35 | 25.15 | 3.8 | 11.44 | 28.75 | 32.04 | 37.85 | 4.97 | Upgrade
|
| Short-Term Investments | 0 | 0 | 0 | 0 | 23.17 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 12.3 | 45.95 | 20.35 | 25.15 | 26.98 | 11.44 | 28.75 | 32.04 | 37.85 | 4.97 | Upgrade
|
| Cash Growth | -73.23% | 125.76% | -19.06% | -6.78% | 135.73% | -60.19% | -10.27% | -15.37% | 661.60% | -3.33% | Upgrade
|
| Other Current Assets | 2.93 | 3.23 | 2.47 | 3.36 | 1.64 | 1.07 | 0.67 | 1.53 | 0.47 | 0.2 | Upgrade
|
| Total Current Assets | 15.23 | 49.18 | 22.82 | 28.51 | 28.62 | 12.51 | 29.42 | 33.57 | 38.32 | 5.17 | Upgrade
|
| Property, Plant & Equipment | 5.64 | 6.37 | 6.76 | 1.03 | 1.27 | 2.41 | 2.8 | 1.81 | 0.58 | 0.15 | Upgrade
|
| Intangible Assets | 0.38 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0.46 | 1.16 | Upgrade
|
| Other Long-Term Assets | 0.62 | 0.27 | 0.32 | 0.35 | 0.36 | 0.31 | 0.19 | 0.21 | 0.03 | 0.03 | Upgrade
|
| Total Long-Term Assets | 6.65 | 7.1 | 7.08 | 1.38 | 1.62 | 2.72 | 2.99 | 2.02 | 1.07 | 1.34 | Upgrade
|
| Total Assets | 21.88 | 56.28 | 29.9 | 29.89 | 30.25 | 15.23 | 32.41 | 35.59 | 39.39 | 6.51 | Upgrade
|
| Accounts Payable | 3.21 | 4.21 | 4.73 | 2.38 | 0 | 3.28 | 0 | 0 | 1.24 | 0.73 | Upgrade
|
| Deferred Revenue | -3.21 | -4.21 | -4.73 | -2.38 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Current Debt | 2.05 | 2.08 | 1.47 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 4.59 | 5.88 | 8.21 | 4.89 | 5.85 | 0.11 | 3.47 | 2.89 | 0.09 | 1.04 | Upgrade
|
| Total Current Liabilities | 6.63 | 7.96 | 9.68 | 4.98 | 5.85 | 3.4 | 3.47 | 2.89 | 1.32 | 1.77 | Upgrade
|
| Long-Term Debt | 4.13 | 5.24 | 6.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Liabilities | 5 | 5 | 0 | 0.64 | 1.47 | 1.14 | 0.89 | 0 | 0 | 0 | Upgrade
|
| Total Long-Term Liabilities | 9.13 | 10.24 | 6.35 | 0.64 | 1.47 | 1.14 | 0.89 | 0 | 0 | 0 | Upgrade
|
| Total Liabilities | 15.76 | 18.2 | 16.03 | 5.61 | 7.32 | 4.54 | 4.35 | 2.89 | 1.32 | 1.77 | Upgrade
|
| Total Debt | 6.17 | 7.32 | 7.82 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Debt Growth | -15.62% | -6.48% | 9242.00% | - | - | - | - | - | - | - | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Retained Earnings | -285.96 | -251.78 | -206.61 | -164.36 | -134.08 | -94.94 | -73.49 | -46.61 | -25.36 | -13.35 | Upgrade
|
| Comprehensive Income | 0.25 | -0.08 | -0.02 | 0.17 | -0.02 | -0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shareholders' Equity | 6.12 | 38.08 | 13.87 | 24.28 | 22.92 | 10.7 | 28.05 | 32.7 | 38.07 | 4.74 | Upgrade
|
| Total Liabilities and Equity | 21.88 | 56.28 | 29.9 | 29.89 | 30.25 | 15.23 | 32.41 | 35.59 | 39.39 | 6.51 | Upgrade
|
| Net Cash / Debt | 6.12 | 38.63 | 12.53 | 25.06 | 26.98 | 11.44 | 28.75 | 32.04 | 37.85 | 4.97 | Upgrade
|
| Net Cash / Debt Growth | -84.15% | 208.34% | -50.01% | -7.09% | 135.73% | -60.19% | -10.27% | -15.37% | 661.60% | -3.33% | Upgrade
|
| Net Cash Per Share | 3.43 | 25.83 | 16.67 | 78.18 | 147.92 | 124.71 | 382.95 | 554.55 | 874.10 | 205.23 | Upgrade
|
| Working Capital | 8.6 | 41.22 | 13.14 | 23.53 | 22.77 | 9.12 | 25.95 | 30.67 | 37 | 3.4 | Upgrade
|
| Book Value Per Share | 3.42 | 25.46 | 18.46 | 75.73 | 125.70 | 116.55 | 373.71 | 565.98 | 879.07 | 195.69 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.